The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Scientists at the University of Minnesota say they've made the first synthetic cell that can complete a life cycle, a major breakthrough that could lead to innovation in the medicine and engineering ...

While many of life's mysteries remain unsolved, every biologist can describe the basic processes performed by a living organism, including energy use, reproduction, growth and development. While these ...

Scientists say they have built a cell from scratch for the first time that can feed, grow and replicate like a natural cell. This breakthrough in synthetic biology could usher in an era of ...

For the very first time, biologists packed nonliving components into a cell-like membrane, piece by piece, and witnessed the bag of molecules start to behave like life. The lab-made synthetic cell ...

Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward ...

Cognito has removed the term “dementia” from its scientific materials, patient resources, clinical study communications and public-facing content. (Pogonici/iStock/Getty Images Plus) Cognito ...

Five years ago, scientists watched in wonder as synthetic bacteria grew and split into daughter cells. The bacteria’s extremely stripped-down genome still supported its entire life cycle. It was a ...

The team simulated a living cell at nanoscale resolution and recapitulated how every molecule within that cell behaved over the course of a full cell cycle. The work took many years: vast computer ...

Cognito Therapeutics has raised $105m to advance the clinical development and commercial preparedness for its Alzheimer's disease therapeutic. The Massachusetts-based company's oversubscribed Series C ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Cambridge company is on its ...

Cognito Therapeutics, a company using visual and auditory stimulation to treat neurodegenerative disorders, announced it closed an oversubscribed $105 million Series C funding round. Morningside ...